Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-182561
Filing Date
2020-06-29
Accepted
2020-06-29 18:17:43
Documents
4
Effectiveness Date
2020-06-30

Document Format Files

Seq Description Document Type Size
1 S-8 d944404ds8.htm S-8 48785
2 EX-5.1 d944404dex51.htm EX-5.1 8032
3 EX-23.1 d944404dex231.htm EX-23.1 1685
4 GRAPHIC g944404ex5_1.jpg GRAPHIC 3790
  Complete submission text file 0001193125-20-182561.txt   64958
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-239537 | Film No.: 20998279
SIC: 2836 Biological Products, (No Diagnostic Substances)